![Dupilumab Provides Clinically Meaningful Responses in Children Aged 6–11 Years with Severe Atopic Dermatitis: Post Hoc Analysis Results from a Phase III Trial | American Journal of Clinical Dermatology Dupilumab Provides Clinically Meaningful Responses in Children Aged 6–11 Years with Severe Atopic Dermatitis: Post Hoc Analysis Results from a Phase III Trial | American Journal of Clinical Dermatology](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs40257-023-00791-7/MediaObjects/40257_2023_791_Fig3_HTML.png)
Dupilumab Provides Clinically Meaningful Responses in Children Aged 6–11 Years with Severe Atopic Dermatitis: Post Hoc Analysis Results from a Phase III Trial | American Journal of Clinical Dermatology
![Dupilumab provides important clinical benefits to patients with atopic dermatitis who do not achieve clear or almost clear skin according to the Investigator's Global Assessment: a pooled analysis of data from two Dupilumab provides important clinical benefits to patients with atopic dermatitis who do not achieve clear or almost clear skin according to the Investigator's Global Assessment: a pooled analysis of data from two](https://onlinelibrary.wiley.com/cms/asset/486de86d-d03f-4590-b6d2-2cd1ad464a37/bjd17791-fig-0003-m.jpg)
Dupilumab provides important clinical benefits to patients with atopic dermatitis who do not achieve clear or almost clear skin according to the Investigator's Global Assessment: a pooled analysis of data from two
![An Open-label, Phase IV Study Evaluating Lidose-isotretinoin Administered without Food in Patients with Severe Recalcitrant Nodular Acne: Low Relapse Rates Observed Over the 104-week Post-treatment Period | JCAD | The Journal of An Open-label, Phase IV Study Evaluating Lidose-isotretinoin Administered without Food in Patients with Severe Recalcitrant Nodular Acne: Low Relapse Rates Observed Over the 104-week Post-treatment Period | JCAD | The Journal of](https://bwcbuildout.com/jcad/wp-content/uploads/DelRossoNov2019Table1.gif)
An Open-label, Phase IV Study Evaluating Lidose-isotretinoin Administered without Food in Patients with Severe Recalcitrant Nodular Acne: Low Relapse Rates Observed Over the 104-week Post-treatment Period | JCAD | The Journal of
![Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)* - Wollenberg - 2021 - British Journal of Dermatology - Wiley Online Library Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)* - Wollenberg - 2021 - British Journal of Dermatology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/7c010dac-fe3e-40ea-b5eb-cc809b0440ce/bjd.v184.3.cover.jpg)
Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)* - Wollenberg - 2021 - British Journal of Dermatology - Wiley Online Library
![The Antibiotic Susceptibility Profile of Cutibacterium Acnes in Maltese Patients with Acne | JCAD | The Journal of Clinical and Aesthetic Dermatology The Antibiotic Susceptibility Profile of Cutibacterium Acnes in Maltese Patients with Acne | JCAD | The Journal of Clinical and Aesthetic Dermatology](https://bwcbuildout.com/jcad/wp-content/uploads/MerciecaTable1June2020.jpg)
The Antibiotic Susceptibility Profile of Cutibacterium Acnes in Maltese Patients with Acne | JCAD | The Journal of Clinical and Aesthetic Dermatology
![Validated Investigator Global Assessment scale for Atopic Dermatitis - Altmeyers Encyclopedia - Department Dermatology Validated Investigator Global Assessment scale for Atopic Dermatitis - Altmeyers Encyclopedia - Department Dermatology](https://cdn.altmeyers.org/media/W1siZiIsImltYWdlcy8yMDIxLzA0LzIzLzEyLzI1LzE1L2I0NDgwYmY4LTY1N2MtNGJhZS04NzNmLTQ0NTliZDdiMGU5Ni92SUdBLUFEIDEuMC5qcGciXSxbInAiLCJ0aHVtYiIsIjEyMDB4OTAwIyJdLFsicCIsImVuY29kZSIsImpwZyJdLFsicCIsImpwZWdvcHRpbSJdXQ/file.jpg?sha=a14fe6166050bf92)
Validated Investigator Global Assessment scale for Atopic Dermatitis - Altmeyers Encyclopedia - Department Dermatology
![Table 5 from Assessment of Intra- and Inter-Rater Reliability of Three Methods for Measuring Atopic Dermatitis Severity: EASI, Objective SCORAD, and IGA | Semantic Scholar Table 5 from Assessment of Intra- and Inter-Rater Reliability of Three Methods for Measuring Atopic Dermatitis Severity: EASI, Objective SCORAD, and IGA | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/328ef70c11aeaba30ec5cbb0b374399a39a7bffb/4-Table5-1.png)
Table 5 from Assessment of Intra- and Inter-Rater Reliability of Three Methods for Measuring Atopic Dermatitis Severity: EASI, Objective SCORAD, and IGA | Semantic Scholar
![Table I from Investigator's Global Assessment of Chronic Prurigo: A New Instrument for Use in Clinical Trials | Semantic Scholar Table I from Investigator's Global Assessment of Chronic Prurigo: A New Instrument for Use in Clinical Trials | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/96a98e9ba5d4080264da09cef206d4712198048f/2-TableI-1.png)
Table I from Investigator's Global Assessment of Chronic Prurigo: A New Instrument for Use in Clinical Trials | Semantic Scholar
Oral Sarecycline for Treatment of Papulopustular Rosacea: Results of a Pilot Study of Effectiveness and Safety - JDDonline - Journal of Drugs in Dermatology
![Investigator's assessment scale (IGA) for acne severity combined with... | Download Scientific Diagram Investigator's assessment scale (IGA) for acne severity combined with... | Download Scientific Diagram](https://www.researchgate.net/publication/351761054/figure/tbl1/AS:1026073848475658@1621646477575/Investigators-assessment-scale-IGA-for-acne-severity-combined-with-post-inflammatory.png)
Investigator's assessment scale (IGA) for acne severity combined with... | Download Scientific Diagram
![Rosacea. Investigator's Global Assessment (IGA) score assessed at week... | Download Scientific Diagram Rosacea. Investigator's Global Assessment (IGA) score assessed at week... | Download Scientific Diagram](https://www.researchgate.net/publication/333449920/figure/fig3/AS:869790134566912@1584385536012/Rosacea-Investigators-Global-Assessment-IGA-score-assessed-at-week-12.png)